Meanwhile, copy number gain in the chromosome 6p22 region, where the ZKSCAN3 gene resides, in bladder cancer has been shown to correlate with the risk of disease progression [11, 12]. Here, ZKSCAN3 is linked to urinary bladder carcinoma.